---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-124742"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:45:00.467970+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Dr. Jeffrey Paley resigns from Journey Medical Board effective Dec 7, 2023

## Summary
- Dr. Jeffrey Paley resigned from the Board of Directors effective December 7, 2023.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced in the filing.

## SEC filing metadata
- accession: 0001104659-23-124742
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465923124742/0001104659-23-124742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465923124742/tm2332500d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-124742
- JSON: https://secwatch.observer/filing/0001104659-23-124742.json
- Plain text: https://secwatch.observer/filing/0001104659-23-124742.txt

## Key facts
- Executive change
  Dr. Jeffrey Paley resigned as Director at Journey Medical Corp.
  - Action: resigned
  - Role: Director
  source text: On December 7, 2023, Dr. Jeffrey Paley submitted his resignation from his position as a member of the Board of Directors (the “Board”) of Journey Medical Corporation (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867066/000110465923124742/0001104659-23-124742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.